InDex Pharmaceuticals Holding AB Stock Nasdaq Stockholm
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- SEK | - |
Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
Mar. 26 | InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 175M 1.92B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.83B | Net income 2025 * | -221M -2.42B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 944M | Net Debt 2025 * | 306M 3.35B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-0.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 |
1st Jan change | Capi. | |
---|---|---|
+24.59% | 672B | |
+24.08% | 550B | |
-5.93% | 351B | |
+15.44% | 317B | |
+7.03% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.80% | 144B | |
-6.96% | 141B |